Why hypoglycemia-induced glucagon secretion becomes impaired in diabetes

Findings indicate that excessive somatostatin inhibits glucagon secretion in type 1 diabetes, offering a novel target for hypoglycemia management strategies.

AdAlta, SYNthesis to form AdCella for advanced cancer treatments

Share this article AdCella will focus on identifying partners with the capability to develop multi-functional cellular immunotherapies. Credit: Lightspring/Shutterstock.com. Australian biotechnology company AdAlta has signed

April 8, 2024

SCHOTT Pharma reinforces commitment to align its climate actions to the requirements of the Paris Agreement – Biotech Investments

EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): ESG SCHOTT Pharma reinforces commitment to align its climate actions to the requirements of the

August 9, 2024

Sonde Health New Cognitive Fitness Health Tracking Solution

What You Should Know: – Sonde Health is expanding its leading health monitoring platform beyond mental and respiratory fitness by introducing an innovative cognitive fitness tracker that allows users to

July 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.